bf/NASDAQ:RIGL_icon.jpeg

NASDAQ:RIGL

Rigel Pharmaceuticals, Inc.

  • Stock

USD

Last Close

10.90

26/07 20:00

Market Cap

150.83M

Beta: 0.73

Volume Today

58.14K

Avg: 2.73M

PE Ratio

−8.04

PFCF: −5.71

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
447K
-
1.12M
151.45%
1.50M
33.10%
4.13M
175.87%
7.87M
90.62%
7.32M
6.95%
average payables
2.80M
-
2.76M
1.50%
2.19M
20.67%
4.16M
90.27%
4.10M
1.53%
4.51M
10.10%
5.27M
16.79%
3.93M
25.46%
3.75M
4.54%
13.15M
250.61%
14.82M
12.72%
average receivables
2.88M
-
5.75M
100%
2.98M
48.23%
101.50K
96.59%
2.04M
-
7.09M
248.00%
13.04M
83.85%
15.72M
20.55%
27.90M
77.43%
35.44M
27.03%
book value per share
2.39
-
1.46
38.68%
1.03
29.37%
0.58
43.58%
0.80
36.66%
0.68
14.09%
0.32
53.03%
0.20
37.28%
0.18
11.64%
-0.08
144.33%
-0.16
108.42%
capex per share
-0.01
-
-0.00
66.32%
-0.01
31.05%
-0.01
37.97%
-0.00
84.76%
-0.01
430.69%
-0.01
26.16%
-0.01
13.96%
-0.00
50.82%
-0.00
29.03%
capex to depreciation
-0.47
-
-0.18
62.83%
-0.38
116.73%
-0.85
125.18%
-0.35
58.72%
-1.86
427.93%
-2.13
14.41%
-1.79
16.09%
-0.54
69.81%
-0.45
16.44%
capex to operating cash flow
0.01
-
0.01
58.27%
0.02
293.87%
0.01
54.57%
0.00
80.04%
0.02
789.13%
0.04
86.43%
0.02
31.01%
-0.11
541.09%
0.01
105.72%
capex to revenue
-0.17
-
-0.05
70.69%
-0.02
62.25%
-0.04
108.75%
-0.04
7.28%
-0.02
32.06%
-0.02
1.24%
-0.01
52.66%
-0.00
63.84%
-0.00
10.92%
cash per share
2.43
-
1.63
32.75%
1.43
12.56%
0.79
44.53%
0.92
15.68%
0.80
12.62%
0.59
26.83%
0.34
42.02%
0.73
115.77%
0.34
53.94%
0.33
3.09%
days of inventory on hand
1.14K
-
545.49
52.02%
668.01
22.46%
2.23K
233.79%
1.90K
14.66%
283.48
85.10%
days payables outstanding
8.13K
-
1.67K
79.42%
1.51K
9.62%
1.28K
15.40%
4.70K
267.25%
366.64
92.19%
days sales outstanding
293.53
-
254.39
13.33%
2.56
98.99%
33.43
-
62.25
86.18%
53.67
13.77%
37.84
29.50%
122.39
223.44%
95.40
22.05%
debt to assets
0.06
-
0.05
18.40%
0.04
9.76%
0.00
94.62%
0.25
-
0.35
43.91%
0.18
48.42%
0.31
69.41%
0.52
67.00%
debt to equity
0.07
-
0.07
2.11%
0.06
11.12%
0.00
95.51%
0.67
-
1.15
70.25%
1.01
12.40%
-3.05
403.27%
-2.11
30.70%
dividend yield
earnings yield
-0.36
-
-0.46
27.66%
-0.19
57.96%
-0.31
60.43%
-0.16
48.36%
-0.19
19.96%
-0.19
2.69%
-0.05
72.30%
-0.04
22.94%
-0.24
500.71%
-0.10
58.25%
enterprise value
227.92M
-
193.06M
15.29%
230.96M
19.63%
210.47M
8.87%
452.13M
114.82%
292.89M
35.22%
372.03M
27.02%
599.35M
61.10%
463.48M
22.67%
275.70M
40.51%
280.12M
1.60%
enterprise value over ebitda
-2.69
-
-2.11
21.41%
-4.46
110.97%
-3.61
19.02%
-5.63
55.84%
-4.03
28.39%
-5.59
38.70%
-21.11
277.69%
-51.91
145.91%
-5.15
90.08%
-13.67
165.50%
ev to operating cash flow
-2.65
-
-2.77
4.51%
-9.86
256.42%
-2.77
71.89%
-5.83
110.20%
-4.98
14.59%
-8.96
80.00%
-11.49
28.15%
78.85
786.54%
-3.74
104.74%
-48.78
1,204.88%
ev to sales
31.88
-
23.40
26.59%
7.99
65.84%
10.33
29.18%
100.83
876.51%
6.58
93.47%
6.27
4.64%
5.52
12.07%
3.11
43.72%
2.29
26.17%
2.40
4.52%
free cash flow per share
-1.00
-
-0.80
19.95%
-0.27
66.15%
-0.81
199.91%
-0.62
24.28%
-0.37
39.32%
-0.26
31.25%
-0.32
23.40%
0.03
109.72%
-0.43
1,497.53%
-0.03
92.33%
free cash flow yield
-0.35
-
-0.35
0.50%
-0.09
74.64%
-0.34
281.82%
-0.16
53.55%
-0.16
2.37%
-0.12
26.11%
-0.09
24.55%
0.01
112.84%
-0.29
2,568.97%
-0.02
92.07%
graham net net
2.27
-
1.39
39.00%
0.97
29.83%
0.55
43.76%
0.77
40.71%
0.64
16.84%
0.08
88.26%
-0.04
149.08%
0.02
146.50%
-0.32
1,955.75%
-0.36
14.19%
graham number
7.40
-
5.84
21.04%
3.68
37.04%
3.10
15.68%
3.33
7.27%
2.60
21.84%
1.70
34.79%
0.90
46.70%
0.65
28.20%
0.80
22.77%
0.73
8.29%
income quality
0.97
-
0.77
20.63%
0.45
40.71%
1.10
141.00%
0.99
9.30%
0.83
16.07%
0.62
25.65%
1.75
182.74%
-0.33
118.70%
1.26
483.77%
0.23
81.82%
intangibles to total assets
0
-
0
0
0
0
0
0
0
0
0.11
Infinity%
0.12
6.34%
interest coverage
-206.24
-
-21.41
89.62%
-1.85
91.38%
-14.63
692.17%
2.98
120.38%
interest debt per share
0.11
-
0.07
30.86%
0.04
49.86%
0.00
93.87%
0.22
-
0.24
9.46%
0.21
13.29%
0.26
26.34%
0.31
17.56%
inventory turnover
0.32
-
0.67
108.43%
0.55
18.34%
0.16
70.04%
0.19
17.18%
1.29
571.25%
invested capital
0.07
-
0.07
2.11%
0.06
11.12%
0.00
95.51%
0.67
-
1.15
70.25%
1.01
12.40%
-3.05
403.27%
-2.11
30.70%
market cap
248.77M
-
198.99M
20.01%
267.96M
34.66%
224.64M
16.16%
490.14M
118.19%
369.22M
24.67%
358.24M
2.97%
590.64M
64.87%
451.80M
23.51%
258.61M
42.76%
252.32M
2.43%
net current asset value
202.27M
-
124.65M
38.37%
88.66M
28.87%
53.11M
40.10%
98.97M
86.36%
107.75M
8.88%
25.25M
76.57%
12.63M
49.98%
17.51M
38.65%
-31.99M
282.68%
-46.60M
45.67%
net debt to ebitda
0.25
-
0.06
73.60%
0.71
999.29%
0.24
65.95%
0.47
94.55%
1.05
121.99%
-0.21
119.73%
-0.31
48.13%
-1.31
326.06%
-0.32
75.59%
-1.36
324.87%
net income per share
-1.02
-
-1.04
1.68%
-0.58
43.88%
-0.73
26.01%
-0.62
15.81%
-0.44
28.89%
-0.40
9.46%
-0.18
54.70%
-0.11
41.66%
-0.36
240.03%
-0.14
59.64%
operating cash flow per share
-0.99
-
-0.80
19.30%
-0.26
66.73%
-0.80
203.69%
-0.61
23.64%
-0.37
40.31%
-0.25
32.33%
-0.31
24.71%
0.03
111.15%
-0.43
1,340.88%
-0.03
92.29%
payables turnover
0.04
-
0.22
385.91%
0.24
10.64%
0.29
18.20%
0.08
72.77%
1.00
1,181.14%
receivables turnover
1.24
-
1.43
15.38%
142.34
9,820.66%
10.92
-
5.86
46.29%
6.80
15.97%
9.65
41.84%
2.98
69.08%
3.83
28.29%
research and ddevelopement to revenue
10.54
-
8.21
22.11%
2.17
73.50%
3.11
43.16%
10.32
231.50%
1.05
89.79%
0.89
15.35%
0.55
37.97%
0.44
21.00%
0.50
14.67%
0.21
58.14%
return on tangible assets
-0.39
-
-0.59
49.76%
-0.39
33.77%
-0.89
126.78%
-0.65
26.09%
-0.51
22.62%
-0.45
10.99%
-0.28
38.94%
-0.11
61.12%
-0.52
382.15%
-0.24
52.97%
revenue per share
0.08
-
0.09
14.89%
0.33
247.18%
0.22
33.91%
0.04
83.56%
0.28
681.11%
0.35
27.74%
0.64
81.74%
0.88
35.99%
0.70
20.32%
0.67
3.69%
roe
-0.43
-
-0.71
65.81%
-0.56
20.55%
-1.26
123.35%
-0.77
38.39%
-0.64
17.22%
-1.24
92.78%
-0.89
27.77%
-0.59
33.97%
4.52
867.03%
0.88
80.64%
roic
-0.43
-
-0.60
40.40%
-0.48
20.51%
-1.20
149.40%
-0.77
35.98%
-0.68
10.89%
-0.59
13.61%
-0.32
45.63%
-0.13
59.51%
-1.90
1,363.06%
-0.62
67.20%
sales general and administrative to revenue
2.74
-
3.85
40.54%
0.62
84.01%
1.03
66.39%
8.44
722.50%
1.57
81.36%
shareholders equity per share
2.39
-
1.46
38.68%
1.03
29.37%
0.58
43.58%
0.80
36.66%
0.68
14.09%
0.32
53.03%
0.20
37.28%
0.18
11.64%
-0.08
144.33%
-0.16
108.42%
stock based compensation to revenue
1.00
-
1.19
18.37%
0.26
78.40%
0.36
40.42%
1.34
271.13%
0.17
87.04%
0.15
11.18%
0.07
56.30%
0.06
5.38%
0.10
62.04%
0.08
26.85%
tangible asset value
208.25M
-
128.25M
38.42%
91.38M
28.75%
55.03M
39.78%
100.65M
82.90%
109.88M
9.17%
53.81M
51.02%
34.03M
36.77%
30.37M
10.73%
-28.57M
194.04%
-42.52M
48.86%
tangible book value per share
2.39
-
1.46
38.68%
1.03
29.37%
0.58
43.58%
0.80
36.66%
0.68
14.09%
0.32
53.03%
0.20
37.28%
0.18
11.64%
-0.17
193.00%
-0.24
47.48%
working capital
209.78M
-
136.51M
34.93%
95.23M
30.24%
53.63M
43.69%
99.10M
84.79%
109.25M
10.25%
60.79M
44.36%
48.14M
20.81%
90.91M
88.84%
50.69M
44.24%
46.00M
9.26%

All numbers in USD (except ratios and percentages)